Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D03EXD
|
||||
| Former ID |
DNC011103
|
||||
| Drug Name |
4-[(4'-Hydroxybiphenyl-4-yl)methyl]pyridine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [531085] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C18H15NO2
|
||||
| Canonical SMILES |
C1=CC(=CC=C1C2=CC=C(C=C2)O)C(C3=CC=NC=C3)O
|
||||
| InChI |
1S/C18H15NO2/c20-17-7-5-14(6-8-17)13-1-3-15(4-2-13)18(21)16-9-11-19-12-10-16/h1-12,18,20-21H
|
||||
| InChIKey |
ABUNZHUAYBOXCN-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | 17 alpha-hydroxylase-C17, 20-lyase | Target Info | Inhibitor | [531085] | |
| Cytochrome P450 11B1, mitochondrial | Target Info | Inhibitor | [531085] | ||
| Cytochrome P450 19 | Target Info | Inhibitor | [531085] | ||
| NetPath Pathway | FSH Signaling Pathway | ||||
| PANTHER Pathway | Androgen/estrogene/progesterone biosynthesis | ||||
| WikiPathways | Metapathway biotransformation | ||||
| Steroid Biosynthesis | |||||
| Oxidation by Cytochrome P450 | |||||
| Metabolism of steroid hormones and vitamin D | |||||
| Glucocorticoid & Mineralcorticoid Metabolism | |||||
| Prostate Cancer | |||||
| Phase 1 - Functionalization of compoundsWP702:Metapathway biotransformation | |||||
| Corticotropin-releasing hormoneWP702:Metapathway biotransformation | |||||
| Tryptophan metabolism | |||||
| Ovarian Infertility Genes | |||||
| FSH signaling pathway | |||||
| Integrated Breast Cancer Pathway | |||||
| Phase 1 - Functionalization of compounds | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.